Therapy of ANCA-associated systemic vasculitides: current approaches


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Modern therapeutic approaches to treatment of ANCA-associated systemic vasculitides and algoritms of treatment choice are presented. Controlled clinical trials in patients with ANCA-associated systemic vasculitides are discussed. Role of target biological therapy of systemic vasculitides is reviewed.

References

Supplementary files

Supplementary Files
Action
1. JATS XML